Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Baran

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Dermatological Treatment|April 19, 2019
Lp-PLA2 as a promising predictor of comorbidities in patients with severe psoriasisPaulina Kiluk, Anna Baran, Magdalena Świderska, et al.
International Journal of Molecular Sciences|May 28, 2020
Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein-Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome?Julita Anna Krahel, Anna Baran, Tomasz W Kamiński, et al.
Advances in Medical Sciences|December 2, 2014
Upregulation of the sFas/sFasL system in psoriatic patientsHanna Myśliwiec, Anna Baran, Piotr Myśliwiec, et al.
Blood Pressure|February 7, 2004
Accuracy of SpaceLabs 90207 is altered by venous blood redistributionMarek Czarkowski, Małgorzata Mikulska, Anna Baran, et al.
Archives of Dermatological Research|April 18, 2019
Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasisAnna Baran, Paulina Kiluk, Magdalena Maciaszek, et al.
Blood Pressure Monitoring|March 17, 2004
Venous blood redistribution alters the accuracy of Omron HEM-705CPMarek Czarkowski, Małgorzata Mikulska, Mariusz ZEbrowski, et al.
Rheumatology International|August 12, 2025
Friend or foe? Sebaceous cyst inflammation during ixekizumab therapy in psoriatic arthritis: case based reviewMarta Całus, Julia Grymuza, Anna Baran, et al.
Journal of Clinical Medicine|December 19, 2019
The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic PatientsPaulina Kiluk, Anna Baran, Tomasz W Kaminski, et al.
Postepy Dermatologii I Alergologii|June 1, 2022
Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary resultsPaulina Kiluk, Anna Baran, Tomasz W Kaminski, et al.
Endokrynologia Polska|December 13, 2005
[Production and preliminary characteristics of polyclonal antibodies specific to SSTR2A and SSTR5 receptors in the pituitary gland]Zbigniew Bartoszewicz, Anna Baran, Anna M Makowska, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Dermatological Treatment|April 19, 2019
Lp-PLA2 as a promising predictor of comorbidities in patients with severe psoriasisPaulina Kiluk, Anna Baran, Magdalena Świderska, et al.
International Journal of Molecular Sciences|May 28, 2020
Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein-Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome?Julita Anna Krahel, Anna Baran, Tomasz W Kamiński, et al.
Advances in Medical Sciences|December 2, 2014
Upregulation of the sFas/sFasL system in psoriatic patientsHanna Myśliwiec, Anna Baran, Piotr Myśliwiec, et al.
Blood Pressure|February 7, 2004
Accuracy of SpaceLabs 90207 is altered by venous blood redistributionMarek Czarkowski, Małgorzata Mikulska, Anna Baran, et al.
Archives of Dermatological Research|April 18, 2019
Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasisAnna Baran, Paulina Kiluk, Magdalena Maciaszek, et al.
Blood Pressure Monitoring|March 17, 2004
Venous blood redistribution alters the accuracy of Omron HEM-705CPMarek Czarkowski, Małgorzata Mikulska, Mariusz ZEbrowski, et al.
Rheumatology International|August 12, 2025
Friend or foe? Sebaceous cyst inflammation during ixekizumab therapy in psoriatic arthritis: case based reviewMarta Całus, Julia Grymuza, Anna Baran, et al.
Journal of Clinical Medicine|December 19, 2019
The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic PatientsPaulina Kiluk, Anna Baran, Tomasz W Kaminski, et al.
Postepy Dermatologii I Alergologii|June 1, 2022
Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary resultsPaulina Kiluk, Anna Baran, Tomasz W Kaminski, et al.
Endokrynologia Polska|December 13, 2005
[Production and preliminary characteristics of polyclonal antibodies specific to SSTR2A and SSTR5 receptors in the pituitary gland]Zbigniew Bartoszewicz, Anna Baran, Anna M Makowska, et al.
Pageof 9